---
title: "Geron begins restructuring that cuts about one-third of its roughly 260"
url: "https://aibio.space/news/geron-begins-restructuring-cuts-about-one-third-roughly-260-employees/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-12-16"
section: "Distress"
tickers: "NASDAQ:GERN"
source: "https://www.sec.gov/Archives/edgar/data/886744/000088674425000074/gern-20251210.htm"
summary: "The company estimates about $18 million in restructuring charges, mostly severance and benefits, hitting results in the fourth quarter of 2025 and the firs"
---

By the aibio.space news desk.

Sources

- [Geron Corporation 8-K (2025-12-16)](https://www.sec.gov/Archives/edgar/data/886744/000088674425000074/gern-20251210.htm)

[GERN](https://aibio.space/companies/geron/)

2025-12-16

# Geron begins restructuring that cuts about one-third of its roughly 260 employees

Tickers [GERN](https://aibio.space/companies/geron/)

The company estimates about $18 million in restructuring charges, mostly severance and benefits, hitting results in the fourth quarter of 2025 and the first quarter of 2026.

## Key facts

- **Company**: Geron Corporation (NASDAQ: GERN)

- **News type**: Distress

- **Primary source**: [Geron Corporation 8-K (2025-12-16)](https://www.sec.gov/Archives/edgar/data/886744/000088674425000074/gern-20251210.htm)

*The White House and its lawn. CC0, via rawpixel. The picture shows the field, not the companies named.*

Geron Corporation (Nasdaq: [GERN](https://aibio.space/companies/geron/)) said in an 8-K that it began implementing a strategic restructuring plan on December 16, 2025. Its Board of Directors unanimously approved the plan on December 10, 2025. The company says the plan is intended to position it for long-term value creation and improve its financial discipline.

The plan includes a reduction in workforce of approximately one-third of its current approximately 260 employees. Geron began notifying affected employees on December 16, 2025, and expects the reduction to be substantially complete in the first quarter of 2026.

Geron estimates it will incur approximately $18 million in restructuring and restructuring-related charges. They consist primarily of one-time employee severance payments, healthcare and related benefits, and other employee-related costs. The company expects the charges to affect results of operations in the fourth quarter of 2025 and the first quarter of 2026, with most cash payments through the first quarter of 2026.

The charges are not currently expected to include any non-cash charges for equity-based compensation or otherwise. Geron cautions that the estimates rest on assumptions, that actual results may differ materially and that it may incur additional costs it does not now contemplate.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

GERN

Geron Corporation

NASDAQ · United States

Open the starter desk

## More in Distress

Distress

### [Mineralys takes ownership of lorundrostat patents but keeps Tanabe milestone debts](https://aibio.space/news/mineralys-takes-ownership-lorundrostat-patents-but-keeps-tanabe/)

Oct 29, 2026

Distress

### [Bristol Myers Squibb drops Prothena's PRX019, ending up to $617.5 million in milestones](https://aibio.space/news/bristol-myers-squibb-drops-prothenas-prx019-ending-up-617-5-million/)

Oct 29, 2026

Distress

### [LENZ Therapeutics reorganizes to cut 2027 operating expenses by more than 50%](https://aibio.space/news/lenz-therapeutics-reorganizes-cut-2027-operating-expenses-more-50/)

Oct 28, 2026

---
Source page: https://aibio.space/news/geron-begins-restructuring-cuts-about-one-third-roughly-260-employees/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Geron begins restructuring that cuts about one-third of its roughly 260", 2025-12-16, https://aibio.space/news/geron-begins-restructuring-cuts-about-one-third-roughly-260-employees/